CM Management’s Atea Pharmaceuticals AVIR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.8M	Hold	500,000	–	–	1.64%	24
2025 Q1	$1.5M	Buy	500,000 +200,000	+67%	+$598K	1.5%	30
2024 Q4	$1.01M	Buy	300,000 +30,000	+11%	+$101K	0.9%	42
2024 Q3	$905K	Hold	270,000	–	–	0.72%	49
2024 Q2	$894K	Hold	270,000	–	–	0.82%	43
2024 Q1	$1.09M	Hold	270,000	–	–	0.92%	43
2023 Q4	$824K	Sell	270,000 -5,000	-2%	-$15.3K	0.66%	46
2023 Q3	$825K	Buy	275,000 +25,000	+10%	+$75K	0.88%	40
2023 Q2	$935K	Sell	250,000 -75,000	-23%	-$281K	0.91%	35
2023 Q1	$1.09M	Buy	325,000 +50,000	+18%	+$168K	1.29%	32
2022 Q4	$1.32M	Buy	275,000 +25,000	+10%	+$120K	1.58%	20
2022 Q3	$1.42M	Buy	250,000 +50,000	+25%	+$285K	1.59%	22
2022 Q2	$1.42M	Hold	200,000	–	–	1.51%	26
2022 Q1	$1.44M	Buy	200,000 +100,000	+100%	+$722K	1.21%	30
2021 Q4	$894K	Hold	100,000	–	–	0.68%	51
2021 Q3	$3.51M	Buy	100,000 +10,000	+11%	+$351K	2.61%	7
2021 Q2	$1.93M	Buy	+90,000	New	+$1.93M	1.4%	20